Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.880
+0.340 (9.60%)
At close: Mar 9, 2026, 4:00 PM EDT
3.840
-0.040 (-1.03%)
After-hours: Mar 9, 2026, 7:37 PM EDT

Altimmune Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
43.836.97135.16111.13190.34
Short-Term Investments
229.794.9762.773.78-
Cash & Short-Term Investments
273.5131.93197.86184.91190.34
Cash Growth
107.30%-33.32%7.00%-2.85%-11.87%
Accounts Receivable
1.220.541.110.170.43
Other Receivables
0.522.573.742.375.41
Total Trade Receivables
1.743.124.852.545.84
Other Current Assets
2.962.26.925.367.95
Total Current Assets
278.19137.25209.63192.81204.13
Net Property, Plant & Equipment
0.310.410.651.081.45
Other Intangible Assets
---12.4212.42
Other Long-Term Assets
1.431.640.360.620.87
Total Assets
279.93139.31210.64206.93218.87
Accounts Payable
2.720.212.074.82.03
Accrued Expenses
12.2810.2610.0712.2510.15
Other Current Liabilities
----6.09
Total Current Liabilities
1510.4712.1417.0518.28
Long-Term Debt
34.29----
Other Long-Term Liabilities
5.755.334.44.581.45
Total Long-Term Liabilities
40.045.334.44.581.45
Total Liabilities
55.0415.816.5421.6419.73
Common Stock
0.010.010.010.010
Additional Paid-in Capital
879.29689.86665.43568.4497.34
Accumulated Other Comprehensive Income
-4.93-4.97-5-5.23-5.04
Retained Earnings
-649.48-561.39-466.33-377.88-293.17
Shareholders' Equity
224.89123.51194.1185.29199.14
Total Liabilities & Equity
279.93139.31210.64206.93218.87
Total Debt
34.290000
Net Cash (Debt)
239.21131.93197.86184.91190.34
Net Cash Growth
81.31%-33.32%7.00%-2.85%-11.87%
Net Cash Per Share
2.711.863.723.944.61
Book Value
224.89123.51194.1185.29199.14
Book Value Per Share
2.551.743.653.954.82
Tangible Book Value
224.89123.51194.1172.87186.72
Tangible Book Value Per Share
2.551.743.653.684.52
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q